Net sales for the first quarter of 2026 were $18.2 million, down from $20.2 million in the same period of 2025. The company reported a net loss of $3.7 million for the quarter, compared to a $0.7 million loss in Q1 2025. Operating expenses increased to $8.5 million, driven by stock-based compensation. A significant $1.6 million impairment loss was recorded on an equity method investment in former parent HCMC. Cash and cash equivalents stood at $2.3 million as of March 31, 2026, with negative working capital of $4.1 million.